TipRanks
Go Ultimate55% OFF

Protagonist Therapeutics (PTGX) Cash flow

Protagonist Therapeutics Cash Flow

PTGX's free cash flow for Q2 2026 was $218.88M. For the 2026 fiscal year, PTGX's free cash flow was decreased by $-168.00K and operating cash flow was $219.05M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ 57.67M$ 184.15M$ -70.24M$ -108.14M$ -107.86M
$ -49.33M$ -299.48M$ -39.26M$ 91.47M$ -15.86M
$ 22.86M$ 25.85M$ 170.48M$ 18.84M$ 129.92M
$ 128.39M$ 97.47M$ 186.95M$ 125.97M$ 123.89M
$ 56.08M$ 182.80M$ -70.84M$ -108.93M$ -108.97M

Currency in USD

Protagonist Therapeutics Cash Flow

-400M-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing